Xiao Hang Tong
Chairman bij Shanghai Cardimed Medical Technology Co. Ltd.
Profiel
Xiao Hang Tong currently works at Shanghai Cardimed Medical Technology Co. Ltd., as Chairman from 2015, AnHeart Therapeutics (Hangzhou) Co., Ltd., as Chairman, Insight Lifetech Co., Ltd., as Non-Executive Director from 2017, and Lingke Pharmaceutical Hangzhou Co., Ltd., as Director from 2020.
Dr. Tong also formerly worked at Suzhou Decheng Life Science Venture Capital (Shanghai), as Vice President-Investment from 2014 to 2020.
Dr. Tong received his undergraduate degree in 2010 from Peking University, undergraduate degree in 2005 from the University of Science & Technology of China, and doctorate degree in 2010 from Chinese Academy of Sciences.
Actieve functies van Xiao Hang Tong
| Bedrijven | Functie | Begin |
|---|---|---|
Insight Lifetech Co., Ltd.
 Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Director/Board Member | 21-06-2017 |
Shanghai Cardimed Medical Technology Co. Ltd.
 Shanghai Cardimed Medical Technology Co. Ltd. Medical DistributorsDistribution Services Shanghai Cardimed Medical Technology Co. Ltd. is a company that distributes hemodialysis and renal care equipment. The company was founded in 2015 and is based in Shanghai, China. | Chairman | 01-10-2015 |
| Lingke Pharmaceutical Hangzhou Co., Ltd. | Director/Board Member | 01-02-2020 |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Chairman | - |
Eerdere bekende functies van Xiao Hang Tong
| Bedrijven | Functie | Einde |
|---|---|---|
| Suzhou Decheng Life Science Venture Capital (Shanghai) | Chief Investment Officer | 01-05-2020 |
Opleiding van Xiao Hang Tong
| Peking University | Undergraduate Degree |
| University of Science & Technology of China | Undergraduate Degree |
| Chinese Academy of Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Shanghai Cardimed Medical Technology Co. Ltd.
Shanghai Cardimed Medical Technology Co. Ltd. Medical DistributorsDistribution Services Shanghai Cardimed Medical Technology Co. Ltd. is a company that distributes hemodialysis and renal care equipment. The company was founded in 2015 and is based in Shanghai, China. | Distribution Services |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |
| Lingke Pharmaceutical Hangzhou Co., Ltd. | |
| Suzhou Decheng Life Science Venture Capital (Shanghai) |
